Time trends over 16 years in incidence-rates of autism spectrum disorders across the lifespan based on nationwide Danish register data.

Jensen et al. (2014) tracked every new autism diagnosis in Denmark for 16 years. They used national birth, health, and psychiatry records. No interviews or lab tests—just the registries.

The team counted how many people got an ASD label each year. They split counts by age, sex, and subtype: childhood autism, Asperger’s, or PDD-NOS.

Diagnoses jumped from 9 to almost 39 per 100 000 people. The rise was steepest in girls, teens, and adults. Asperger’s and PDD-NOS drove most of the increase.

In plain words, Denmark’s autism rate quadrupled. The surge came from recognizing milder traits in people once missed.

Edgin et al. (2017) helps explain the jump. They showed new U.S. Autistic Disorder cases are milder today than 15 years ago. Both papers point to the same trend: doctors now catch less severe symptoms, so counts rise even though kids are not “more autistic.”

Whitehouse et al. (2014) and Diemer et al. (2023) trace the real-world fallout. U.S. autism hospitalizations tripled while Ontario’s per-child health bill climbed to $33 000 over ten years. Denmark’s boom in labels predicts similar service pressure wherever you practice.

Noterdaeme et al. (2010) and Shrestha et al. (2014) add global context. German kids wait five years from first signs to diagnosis; Nepali kids wait nearly two and a half after seeing a doctor. Long delays mean many cases hide in the numbers, then surface in sudden spikes like Denmark’s.

Your caseload is growing because we’re better at seeing autism, not because autism is exploding. Plan for more older clients, more girls, and more “mild” presentations that still need solid ABA. Use the Danish curve when directors ask why referrals keep coming—then show Edgin et al. (2017) to prove severity is steady. Push for early screening and flexible funding now, before the wave hits your waitlist.